Drug reference
dextroamphetamine
CNS Stimulant
CNS Stimulant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
Depression in terminally ill patientsFatigueOpioid-induced somnolenceNarcolepsy
Dosing
- Adult
- 2.5–5.0 mg in the morning and at noon, escalated up to 15 mg bid
Pharmacokinetics
Bioavailability
—
Protein binding
Rac: 23–26%
Excretion
Rac: 14.5%
Side effects
Common
initial anxietyinsomniaSympathomimetic side effectsAnxiety
Serious
- paranoia (rarely)
Related guidelines
Other Unclassified drugs
Ask House about dextroamphetamine
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e, Harrison 22e·Updated: 2026-05-10